TMPRSS13 and colorectal carcinoma: These findings lay the foundation for continuing studies to further decipher the molecular mechanisms by which TMPRSS13 exerts its pro-oncogenic functions, to promote the development of TMPRSS13 inhibitors, and to study their potential as targeted therapeutic drugs in CRC.